For the first time in three decades, Australian women living with endometriosis will have access to a new treatment subsidised by the federal government.

Health Minister Mark Butler yesterday announced the listing of Visanne (Dienogest), a daily tablet that works to shrink and supress the growth of abnormal tissue, on the Pharmaceutical Benefits Scheme (PBS).

More than one million Australian women live with endometriosis, often experiencing crippling pain. There is no cure, and it can last for decades. Endometriosis currently results in over 40,000 hospital admissions each year.

Under the changes, the annual cost of a course of daily tablets will halve from $750 to about $380.

In a sign of increasing awareness about the condition, the Albanese Government continues to invest in numerous support strategies, including establishing 22 specialist Endometriosis and Pelvic Pain Clinics across the country.

“For too long, women living with endometriosis have had to struggle in silence,” Mr Butler said.

“Women are suffering unnecessarily. They’re having their experiences dismissed, being called hysterical and accused of drug shopping. Women’s pain is real and it’s time we stop telling women to just suck it up.
“Making this medicine cheaper for women is going to be transformative.”